Logo image of ADNT

ADIENT PLC (ADNT) Stock Fundamental Analysis

NYSE:ADNT - New York Stock Exchange, Inc. - IE00BD845X29 - Common Stock - Currency: USD

21.74  +0.03 (+0.14%)

Fundamental Rating

3

ADNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. ADNT may be in some trouble as it scores bad on both profitability and health. ADNT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ADNT had positive earnings in the past year.
In the past year ADNT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ADNT reported negative net income in multiple years.
Each year in the past 5 years ADNT had a positive operating cash flow.
ADNT Yearly Net Income VS EBIT VS OCF VS FCFADNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

ADNT has a Return On Assets of -3.11%. This is amonst the worse of the industry: ADNT underperforms 82.50% of its industry peers.
ADNT has a Return On Equity of -16.16%. This is amonst the worse of the industry: ADNT underperforms 82.50% of its industry peers.
The Return On Invested Capital of ADNT (6.40%) is worse than 70.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADNT is below the industry average of 8.73%.
The last Return On Invested Capital (6.40%) for ADNT is above the 3 year average (5.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -3.11%
ROE -16.16%
ROIC 6.4%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ADNT Yearly ROA, ROE, ROICADNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

In the last couple of years the Profit Margin of ADNT has declined.
ADNT has a worse Operating Margin (2.98%) than 80.00% of its industry peers.
ADNT's Operating Margin has improved in the last couple of years.
ADNT has a Gross Margin of 6.52%. This is amonst the worse of the industry: ADNT underperforms 93.75% of its industry peers.
ADNT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.98%
PM (TTM) N/A
GM 6.52%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
ADNT Yearly Profit, Operating, Gross MarginsADNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

ADNT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ADNT has been reduced compared to 1 year ago.
ADNT has less shares outstanding than it did 5 years ago.
ADNT has a better debt/assets ratio than last year.
ADNT Yearly Shares OutstandingADNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ADNT Yearly Total Debt VS Total AssetsADNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ADNT has an Altman-Z score of 1.85. This is not the best score and indicates that ADNT is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ADNT (1.85) is worse than 76.25% of its industry peers.
ADNT has a debt to FCF ratio of 10.24. This is a negative value and a sign of low solvency as ADNT would need 10.24 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.24, ADNT is doing worse than 72.50% of the companies in the same industry.
A Debt/Equity ratio of 1.45 is on the high side and indicates that ADNT has dependencies on debt financing.
ADNT has a Debt to Equity ratio of 1.45. This is amonst the worse of the industry: ADNT underperforms 88.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.45
Debt/FCF 10.24
Altman-Z 1.85
ROIC/WACC1.15
WACC5.54%
ADNT Yearly LT Debt VS Equity VS FCFADNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

A Current Ratio of 1.11 indicates that ADNT should not have too much problems paying its short term obligations.
ADNT's Current ratio of 1.11 is on the low side compared to the rest of the industry. ADNT is outperformed by 91.25% of its industry peers.
A Quick Ratio of 0.90 indicates that ADNT may have some problems paying its short term obligations.
ADNT has a Quick ratio of 0.90. This is amonst the worse of the industry: ADNT underperforms 83.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.9
ADNT Yearly Current Assets VS Current LiabilitesADNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The earnings per share for ADNT have decreased strongly by -16.24% in the last year.
ADNT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.56% yearly.
The Revenue has decreased by -5.33% in the past year.
The Revenue has been decreasing by -2.33% on average over the past years.
EPS 1Y (TTM)-16.24%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%27.78%
Revenue 1Y (TTM)-5.33%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%-3.71%

3.2 Future

The Earnings Per Share is expected to grow by 33.50% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 1.10% on average over the next years.
EPS Next Y-1.38%
EPS Next 2Y11.43%
EPS Next 3Y26.83%
EPS Next 5Y33.5%
Revenue Next Year-3.15%
Revenue Next 2Y-1.85%
Revenue Next 3Y-0.29%
Revenue Next 5Y1.1%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ADNT Yearly Revenue VS EstimatesADNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
ADNT Yearly EPS VS EstimatesADNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

ADNT is valuated reasonably with a Price/Earnings ratio of 11.09.
67.50% of the companies in the same industry are more expensive than ADNT, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.24, ADNT is valued rather cheaply.
The Price/Forward Earnings ratio is 9.46, which indicates a very decent valuation of ADNT.
The rest of the industry has a similar Price/Forward Earnings ratio as ADNT.
The average S&P500 Price/Forward Earnings ratio is at 36.42. ADNT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.09
Fwd PE 9.46
ADNT Price Earnings VS Forward Price EarningsADNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

73.75% of the companies in the same industry are more expensive than ADNT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ADNT is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.81
EV/EBITDA 4.59
ADNT Per share dataADNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as ADNT's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)N/A
PEG (5Y)4.33
EPS Next 2Y11.43%
EPS Next 3Y26.83%

0

5. Dividend

5.1 Amount

No dividends for ADNT!.
Industry RankSector Rank
Dividend Yield N/A

ADIENT PLC

NYSE:ADNT (8/5/2025, 10:35:08 AM)

21.74

+0.03 (+0.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners97.63%
Inst Owner Change0.44%
Ins Owners0.95%
Ins Owner Change2.71%
Market Cap1.83B
Analysts51.25
Price Target23.76 (9.29%)
Short Float %7.94%
Short Ratio5.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.49%
Min EPS beat(2)39.64%
Max EPS beat(2)101.33%
EPS beat(4)3
Avg EPS beat(4)29.7%
Min EPS beat(4)-49.75%
Max EPS beat(4)101.33%
EPS beat(8)5
Avg EPS beat(8)25.6%
EPS beat(12)7
Avg EPS beat(12)31.37%
EPS beat(16)8
Avg EPS beat(16)-9.81%
Revenue beat(2)1
Avg Revenue beat(2)1.37%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)2.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-4.77%
Max Revenue beat(4)2.79%
Revenue beat(8)3
Avg Revenue beat(8)-0.9%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)6
Avg Revenue beat(16)-0.9%
PT rev (1m)38.53%
PT rev (3m)53.8%
EPS NQ rev (1m)15.22%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)0.77%
EPS NY rev (3m)16.6%
Revenue NQ rev (1m)1.84%
Revenue NQ rev (3m)3.78%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)1.77%
Valuation
Industry RankSector Rank
PE 11.09
Fwd PE 9.46
P/S 0.13
P/FCF 7.81
P/OCF 3.77
P/B 1.11
P/tB N/A
EV/EBITDA 4.59
EPS(TTM)1.96
EY9.02%
EPS(NY)2.3
Fwd EY10.57%
FCF(TTM)2.79
FCFY12.81%
OCF(TTM)5.77
OCFY26.55%
SpS171.2
BVpS19.66
TBVpS-5.57
PEG (NY)N/A
PEG (5Y)4.33
Profitability
Industry RankSector Rank
ROA -3.11%
ROE -16.16%
ROCE 8.43%
ROIC 6.4%
ROICexc 7.51%
ROICexgc 14.72%
OM 2.98%
PM (TTM) N/A
GM 6.52%
FCFM 1.63%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ROICexc(3y)6.22%
ROICexc(5y)5.21%
ROICexgc(3y)13.54%
ROICexgc(5y)10.98%
ROCE(3y)6.73%
ROCE(5y)5.58%
ROICexcg growth 3Y4.55%
ROICexcg growth 5Y38.95%
ROICexc growth 3Y0.66%
ROICexc growth 5Y34.59%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
F-Score4
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 1.45
Debt/FCF 10.24
Debt/EBITDA 3.17
Cap/Depr 76.99%
Cap/Sales 1.74%
Interest Coverage 250
Cash Conversion 64.32%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.9
Altman-Z 1.85
F-Score4
WACC5.54%
ROIC/WACC1.15
Cap/Depr(3y)73.03%
Cap/Depr(5y)79.22%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.24%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%27.78%
EPS Next Y-1.38%
EPS Next 2Y11.43%
EPS Next 3Y26.83%
EPS Next 5Y33.5%
Revenue 1Y (TTM)-5.33%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%-3.71%
Revenue Next Year-3.15%
Revenue Next 2Y-1.85%
Revenue Next 3Y-0.29%
Revenue Next 5Y1.1%
EBIT growth 1Y-13.88%
EBIT growth 3Y-5.76%
EBIT growth 5Y30.09%
EBIT Next Year63.86%
EBIT Next 3Y22.46%
EBIT Next 5Y23.5%
FCF growth 1Y15.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.05%
OCF growth 3Y30.56%
OCF growth 5Y12.01%